1. ⁸²Rb PET/CT: entering a new area of myocardial perfusion imaging?

   • Ines Valenta
   • Thomas Hellmut Schindler

   Editorial Commentary 01 June 2012 Pages: 1231 - 1232

2. ⁸²Rb PET myocardial perfusion imaging is superior to ^99mTc-labelled agent SPECT in patients with known or suspected coronary artery disease

   • Albert Flotats
   • Paco E. Bravo
   • Frank M. Bengel

   Short Communication 31 May 2012 Pages: 1233 - 1239

   

3. Parametric imaging of myocardial viability using ¹⁵O-labelled water and PET/CT: comparison with late gadolinium-enhanced CMR

   • Stefan de Haan
   • Hendrik J. Harms
   • Paul Knaapen

   Original Article Open access 11 May 2012 Pages: 1240 - 1245

   

4. Cardiac β-adrenergic receptor density and myocardial systolic function in the remote noninfarcted region after prior myocardial infarction with left ventricular remodelling

   • Nobuyuki Ohte
   • Hitomi Narita
   • Genjiro Kimura

   Original Article 16 May 2012 Pages: 1246 - 1253

   

5. Evaluation of ischaemia in obese patients: feasibility and accuracy of a low-dose protocol with a cadmium-zinc telluride camera

   • Alessia Gimelli
   • Matteo Bottai
   • Paolo Marzullo

   Original Article 15 June 2012 Pages: 1254 - 1261

   

6. Toward tailored medicine (and beyond): the phaeochromocytoma and paraganglioma model

   • Vincenzo Cuccurullo
   • Luigi Mansi

   Editorial Commentary 30 May 2012 Pages: 1262 - 1265

7. A comparison of the performance of ⁶⁸Ga-DOTATATE PET/CT and ¹²³I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma

   • J. B. Maurice
   • R. Troke
   • T. Tan

   Short Communication 20 April 2012 Pages: 1266 - 1270

   

8. Comparison of ⁶⁸Ga-DOTATATE and ⁶⁸Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours

   • Levent Kabasakal
   • Emre Demirci
   • Bedii Kanmaz

   Original Article 20 April 2012 Pages: 1271 - 1277

   

9. Is ⁶⁸Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?

   • Valentina Ambrosini
   • Davide Campana
   • Stefano Fanti

   Original Article 15 May 2012 Pages: 1278 - 1283

10. PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma

    • Heribert Hänscheid
    • Reinhart A. Sweeney
    • Frederik A. Verburg

    Short Communication 20 April 2012 Pages: 1284 - 1288

    

11. Imaging proliferation of ¹⁸F-FLT PET/CT correlated with the expression of microvessel density of tumour tissue in non-small-cell lung cancer

    • Wenfeng Yang
    • Yongming Zhang
    • Jinming Yu

    Original Article 12 May 2012 Pages: 1289 - 1296

    

12. Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy

    • Chia-Hung Kao
    • Shih-Chieh Lin
    • Shang-Wen Chen

    Original Article 25 April 2012 Pages: 1297 - 1305

    

13. Hepatic artery injection of ¹³¹I-labelled metuximab combined with chemoembolization for intermediate hepatocellular carcinoma: a prospective nonrandomized study

    • Lu Wu
    • Ye-Fa Yang
    • Meng-Chao Wu

    Original Article 16 May 2012 Pages: 1306 - 1315

    

14. Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institution

    • Torsten Hinz
    • Hojjat Ahmadzadehfar
    • Monika-H. Schmid-Wendtner

    Original Article 23 May 2012 Pages: 1316 - 1325

    

15. Estimating the whole bone-marrow asset in humans by a computational approach to integrated PET/CT imaging

    • Gianmario Sambuceti
    • Massimo Brignone
    • Francesco Frassoni

    Original Article 26 May 2012 Pages: 1326 - 1338

    

16. Role of scintigraphy with ^99mTc-infliximab in predicting the response of intraarticular infliximab treatment in patients with refractory monoarthritis

    • F. Conti
    • G. Malviya
    • A. Signore

    Original Article 16 May 2012 Pages: 1339 - 1347

    

17. Use of FDG PET/CT for investigation of febrile neutropenia: evaluation in high-risk cancer patients

    • Stephen D. Guy
    • Adrian R. Tramontana
    • Monica A. Slavin

    Original Article 15 May 2012 Pages: 1348 - 1355

    

18. ¹³¹I gastric uptake with and without omeprazole in patients undergoing radioiodine therapy for differentiated thyroid carcinoma

    • Gabriel Castro
    • Isabel Berrocal
    • Patricio González

    Letter to the Editor 30 March 2012 Pages: 1356 - 1357

    

19. Nuclear medicine, scientific publishing and the era of cost containment: what factors hold the key?

    • Sandip Basu

    Letter to the Editor 14 April 2012 Pages: 1358 - 1359

20. Further considerations on adverse reactions to radiopharmaceuticals

    • Massimo Salvatori
    • Giorgio Treglia
    • Nadia Mores

    Letter to the Editor 20 April 2012 Pages: 1360 - 1362

    

21. Clyde N. Cole, Stanley M. Shaw and Richard J. Kowalsky (Eds): Nuclear Pharmacy Quick Reference

    • Filippo Lodi
    • Stefano Boschi

    Book Review 27 April 2012 Pages: 1363 - 1364

22. Francis A. Burgener, Christopher Herzog, Steven P. Meyers, Wolfgang Zaunbauer (eds): Differential Diagnosis in Computed Tomography (2nd edition)

    • Valeria Gaudieri
    • Luigi Mansi

    Book Review 20 April 2012 Pages: 1365 - 1365

23. Relapsing polychondritis detected in PET/CT

    • Rafał Czepczyński
    • Izabela Guzikowska-Ruszkowska
    • Anna Wyszomirska

    Image of the Month Open access 20 April 2012 Pages: 1366 - 1367

    

24. Acute intramural haematoma of the ascending aorta

    • L. Govaerts
    • N. Withofs
    • R. Hustinx

    Image of the Month 20 April 2012 Pages: 1368 - 1369